Today (10/26), Moderna, a top Biopharmaceutical employer, agreed to supply Qatar with their candidate COVID-19 vaccine, which has not yet been approved by any regulatory body. Moderna is currently scaling up their global manufacturing capabilities to be able to produce and distribute up to 1 billion doses per year beginning in 2021. Moderna hopes to have their vaccine approved by the U.S. Food and Drug Administration (FDA), as they mentioned in their forward-looking statements.
Learn more here.
More on: News Regulatory